Evidence map›Paper›PMID 35051350›Full record

ArticleMolecular cell2022

Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing.

Nicole M Martinez, Amanda Su, Margaret C Burns, Julia K Nussbacher, Cassandra Schaening, Shashank Sathe, Gene W Yeo, Wendy V Gilbert

Open access · greenAbstract read
In one paragraph

Article in Molecular cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed, 188 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pseudouridine synthase 7 as a context-specific therapeutic target in cancer.The Journal of pharmacology and experimental therapeutics · 2026
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nicole M MartinezYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, CT 06520, USA.
Amanda SuYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, CT 06520, USA.
Margaret C BurnsDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
Julia K NussbacherDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
Cassandra SchaeningDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Shashank SatheDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
Gene W YeoDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA 92037, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA 92037, USA. Electronic address: geneyeo@ucsd.edu.
Wendy V GilbertYale School of Medicine, Department of Molecular Biophysics & Biochemistry, New Haven, CT 06520, USA. Electronic address: wendy.gilbert@yale.edu.
University of California San Diego · USYale University · USMassachusetts Institute of Technology · US

Funding

Functional RNA elements in the human genomeR01HG004659 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Kevin Daniel Corbett, Eugene Wei-Ming Yeo · 2008 to 2026
$12.4M
A Comprehensive Functional Map of Human Protein-RNA InteractionsU41HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R. · 2018 to 2021
$9.4M
A comprehensive binding and functional map of human RNA-binding proteinsU24HG009889 · NHGRI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R., YEO, EUGENE WEI-MING · 2022 to 2025
$5.5M
Graduate Training in Computational and Systems BiologyT32GM087237 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI BURGE, CHRISTOPHER B · 2009 to 2023
$4.6M
MOLECULAR BIOLOGICAL APPROACHES TO ENDOCRINOLOGYT32DK007541 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GAULTON, KYLE JEFFRIE, MAJITHIA, AMIT · 1987 to 2022
$4.5M
Regulation and Function of snoRNA GenesR01GM101316 · NIGMS · YALE UNIVERSITY · PI Wendy Victoria Gilbert · 2014 to 2026
$3.9M
Role of pseudouridines in pre-mRNA processingR00GM135537 · NIGMS · STANFORD UNIVERSITY · PI MARTINEZ, NICOLE · 2022 to 2024
$747k
Role of pseudouridines in pre-mRNA processingK99GM135537 · NIGMS · YALE UNIVERSITY · PI MARTINEZ, NICOLE · 2020 to 2021
$145k
NHGRI NIH HHS R01 HG004659NHGRI NIH HHS U24 HG009889NHGRI NIH HHS U41 HG009889NIDDK NIH HHS T32 DK007541NIGMS NIH HHS K99 GM135537NIGMS NIH HHS R00 GM135537NIGMS NIH HHS R01 GM101316NIGMS NIH HHS T32 GM087237
6 · The paper itself

Abstract

Pseudouridine is a modified nucleotide that is prevalent in human mRNAs and is dynamically regulated. Here, we investigate when in their life cycle mRNAs become pseudouridylated to illuminate the potential regulatory functions of endogenous mRNA pseudouridylation. Using single-nucleotide resolution pseudouridine profiling on chromatin-associated RNA from human cells, we identified pseudouridines in nascent pre-mRNA at locations associated with alternatively spliced regions, enriched near splice sites, and overlapping hundreds of binding sites for RNA-binding proteins. In vitro splicing assays establish a direct effect of individual endogenous pre-mRNA pseudouridines on splicing efficiency. We validate hundreds of pre-mRNA sites as direct targets of distinct pseudouridine synthases and show that PUS1, PUS7, and RPUSD4-three pre-mRNA-modifying pseudouridine synthases with tissue-specific expression-control widespread changes in alternative pre-mRNA splicing and 3' end processing. Our results establish a vast potential for cotranscriptional pre-mRNA pseudouridylation to regulate human gene expression via alternative pre-mRNA processing.

Indexed as

Alternative SplicingRNA 3' End ProcessingTranscription, GeneticCarcinoma, HepatocellularGene Expression Regulation, NeoplasticHEK293 CellsHep G2 CellsHumansIntramolecular TransferasesLiver NeoplasmsRNA, MessengerRNA PrecursorsIntramolecular Transferasespseudouridine synthasesPUS7 protein, humanRNA, MessengerRNA Precursorsalternative cleavage and polyadenylationalternative splicingcotranscriptionalepitranscriptomemRNA modificationpre-mRNA processingpseudouridinepseudouridine synthaseRNA modification

Identifiers

PMID35051350
PMCPMC8859966
OpenAlexW4205160745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.